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Replicative senescence limits the proliferation of somatic cells











is defined as β
 
-galactosidase activity detectable at pH 6.0
in senescent cells, but the origin of SA-β
 
-gal and its cellular
roles in senescence are not known. We demonstrate here that
SA-β
 




, the gene encoding
lysosomal β
 
-D-galactosidase, the activity of which is typically





-gangliosidosis, which have defective
lysosomal β
 
-galactosidase, did not express SA-β
 
-gal at late
passages even though they underwent replicative senes-
cence. In addition, late passage normal fibroblasts expressing











mRNA depletion also prevented expression of SA-β
 
-gal
activity in HeLa cervical carcinoma cells induced to enter
a senescent state by repression of their endogenous
human papillomavirus E7 oncogene. SA-β
 
-gal induction
during senescence was due at least in part to increased
expression of the lysosomal β
 
-galactosidase protein.
These results also indicate that SA-β
 
-gal is not required
for senescence.









Normal somatic cells proliferate for a limited number of dou-
blings in culture and then enter an irreversible growth-arrested
stage called replicative senescence (Campisi, 2005). Key pheno-

















., 1995), and high-level autofluorescence due to lipofuscin


















., 1996), and senescent cells produce
high levels of reactive oxygen species (ROS) and contain elevated









2005). Permanent growth arrest that displays many of the
features of replicative senescence can also be acutely induced









., 1998), exposure to





., 1995; Shay & Roninson, 2004), and introduction
or activation of tumor suppressor genes (Bringold & Serrano,
2000; Hwang, 2002). Cellular senescence is viewed as a model
for certain aspects of cellular and organismal aging (Campisi,
2005), but the relationship between senescence and aging
remains to be established. In addition, several recent studies
strongly suggest that senescence plays a role in tumor suppres-










-galactosidase activity detectable at pH 6.0 in
cultured cells undergoing replicative or induced senescence but













 staining using a chro-




-gal activity has been the most extensively utilized biomarker
for senescence because of the simplicity of the assay method
and its apparent specificity for senescent cells. It is not clear





-gal activity has been detected in organs of old
individuals and animals, suggesting that cellular senescence is
a feature of organismal aging and that senescent cells accumu-
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2003). In some cases, the identification of cells as senescent









-gal as a marker of




-gal activity has not been con-
clusively determined, and its role in senescence, if any, is





galactosidase activity at pH 6.0 can be detected in cells in
various nonsenescent states, such as extended incubation at








































., 2000; Coates, 2002; Cristofalo,
2005; Yang & Hu, 2005).





determine the basis for its induction during senescence and its
suitability as a marker that unambiguously identifies senescent









-D-galactosidase (EC 3.3.1.23) that is
localized to lysosomes of mammalian cells. Consistent with





displays maximal activity between pH 4.0 and 4.5 but markedly























is readily detectible in these cells at acidic pH. Nevertheless,
based on indirect physiological experiments, it has been pro-



















is higher in late-passage compared to early-passage cells at



















Gary & Kindell, 2005; Yang & Hu, 2005). Furthermore, the














-galactosidase activity increases in senescent
cells due to increased lysosome content, surpassing a threshold





2000; Gary & Kindell, 2005). However, no experiments have









-galactosidase protein in senescent cells, and not due to
increased activity of another enzyme capable of catalyzing



























-galactosidase protein increase during senescence.
















-gangliosidosis fibroblasts with inactivating 











-gangliosidosis patients. Patients with this





(EC 3.2.1.23) activity (Dacremont & Kint, 1968; Norden & O’Brien,









) revealed the existence of a homo-
zygous arg201cys mutation in SKa cells and a homozygous
arg59his mutation in JNa cells. Both mutations are known to




-galactosidase activity and GM1-
gangliosidosis (Silva et al., 1993; Oshima et al., 1994; Caciotti
et al., 2005). As expected, extracts of cultured SKa and JNa
fibroblasts contained low levels of β-galactosidase activity
measured at pH 4.5 as compared to the normal fibroblasts
(Fig. 1A). Furthermore, when SKa and JNa fibroblasts were
incubated in the presence of X-gal at pH 4.5, no cells stained
positively, whereas virtually all of the normal fibroblasts stained
intensely (data not shown).
Replicative senescence in GM1-gangliosidosis 
fibroblasts
Proliferation of the SKa and JNa fibroblasts reached a Hayflick
limit (Hayflick & Moorhead, 1961) after comparable numbers
of population doublings (PD) in cell culture. As judged by the
lack of a significant increase in cell number during a 20-day
culture period, the control normal fibroblasts proliferated to
PD75, whereas the SKa and JNa fibroblasts proliferated to
approximately PD59 and PD58, respectively (data not shown).
(The PD number for the GM1-gangliosidosis cells is an under-
estimate because PD numbers at some early passages were
not recorded). The acquisition of a senescent state in these late-
passage cells was confirmed by several criteria in addition to
growth retardation. In senescent normal fibroblasts, the levels of
p53 and p21WAF1 or p16INK4a are high, the p105Rb retinoblastoma
protein is primarily hypophosphorylated, and cellular levels of
autofluorescence and ROS increase. At late passages, the
normal and GM1-gangliosidosis cell strains displayed elevated
levels of p53 and p21WAF1 as well as hypophosphorylated
Rb (Fig. 1B shows the status of p21WAF1 as a representative
example). All three cell strains also displayed increased cell size,
flattened morphology, autofluorescence, and ROS at the late
passages but not at the early passages (Fig. 1C and data not
shown). Similar changes in all three cell strains at early passage
were also elicited by adriamycin treatment, which induces a
state of senescence in normal fibroblasts (B.Y.L. and E.S.H.,
unpublished result). Taken together, these results indicate
that senescence could be imposed on the GM1-gangliosidosis
fibroblasts either by prolonged replication in culture or by
chemical stress.
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Absence of SA-β-gal activity in GM1-gangliosidosis 
fibroblasts
The senescent SKa and JNa fibroblasts were analyzed for SA-
β-gal activity in situ by incubation with X-gal at pH 6.0.
Although the great majority of normal cells stained positively
for SA-β-gal activity at late passage, none of the late-passage
SKa or JNa cells stained (Fig. 2A). Enzymatic activity assays in
cell extracts also demonstrated very low β-galactosidase activity
at pH 6.0 in senescent GM1-gangliosidosis fibroblasts, whereas
the late-passage normal cells displayed high level SA-β-gal
activity (approximately sixfold higher than the level in early-
passage cells) (Fig. 2B). Similarly, adriamycin-treated normal
fibroblasts, but not GM1-gangiosidosis fibroblasts, displayed
in situ SA-β-gal activity (data not shown). Therefore, SA-β-gal
activity is absent or markedly reduced in GM1-gangliosidosis
fibroblasts, which are devoid of active lysosomal β-galactosidase
due to inactivating mutations in the GLB1 gene, strongly sug-
gesting that lysosomal β-galactosidase is the origin of SA β-gal
activity.
Decreased SA-β-gal activity in late-passage fibroblasts 
expressing GLB1 interfering RNA
We used an independent approach to confirm the origin of SA-
β-gal activity. Pre-senescent (PD62) normal fibroblasts were
infected in parallel with retroviruses that expressed two differ-
ent small hairpin interfering RNAs (shRNA) targeting GLB1
mRNA, along with the gene for puromycin-resistance, or with
a control retrovirus. Following puromycin selection, pooled cell
lines were established and analyzed. Real-time RT-PCR demon-
strated that the level of GLB1 mRNA decreased by 7.3- and 5.6-
fold, respectively, in two independent lines that express shRNA
targeting either of two different sites in the GLB1 mRNA (data
not shown). Repression of lysosomal β-galactosidase expression
was confirmed by Western blotting (see Fig. 4, lane 5). The level
of GLB1 mRNA was not affected in control cells that express
Photinus luciferase shRNA (shLUC). In both GLB1-knockdown
fibroblast lines, β-galactosidase activity measured at pH 4.5 in
solution was reduced to less than 20% of that in the cells
expressing luciferase shRNA or the parent cells at similar passage
Fig. 1 Characterization of GM1-gangliosidosis fibroblasts. (A) 10
5 early-passage normal, JNa, and SKa fibroblasts were lysed in 100 µL of 0.1 M citrate buffer 
(pH 4.5). Equal volumes of extract were assayed in solution for acidic β-galactosidase activity (pH 4.5) using ONPG as substrate. Each bar shows the average 
of three assays with the cells prepared at either PD23 (black bars) or PD26 (gray bars). (B) p21WAF1 levels in normal, SKa, and JNa cells. Extracts (20 µg protein) 
from cells collected either at early passage (E) (PD18 for the normal and SKa cells, and PD24 for JNa) or late passage (L) (PD74, PD58, and PD56 for the normal, 
SKa, and JNa cells, respectively) were subjected to Western blotting for p21WAF1 and Erk-1/2. (C) Early- and late-passage fibroblasts were mounted and examined 
by fluorescence (bottom panels) and phase contrast microscopy (top panels). NHF, normal human fibroblasts.
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(Fig. 3A), and fewer than 10% of GLB1-knockdown fibroblasts
positively stained in situ for acidic β-galactosidase at pH 4.5
(data not shown). Cells expressing GLB1 shRNA and control cells
were passaged until they ceased proliferation and assumed a
senescent morphology (at estimated PD73), at which time they
were analyzed for in situ SA-β-gal activity at pH 6.0 (Fig. 3B and
Table 1). As expected, many cells in the population of both the
parental and the control shLUC lines positively stained. Strik-
ingly, only rare GLB1-knockdown cells stained for SA-β-gal
activity at pH 6.0, and the intensity of staining was in general
lower in the rare positive cells (e.g. shGLB#2, Fig. 3B). In addition,
β-galactosidase activity measured in solution at pH 6.0 was
approximately 16.7% of the activity of the parent normal human
fibroblasts (data not shown). Thus, GLB1 mRNA suppression
markedly inhibited SA-β-gal activity in senescent fibroblasts.
Decreased SA-β-gal activity in senescent HeLa cells 
expressing GLB1 interfering RNA
HeLa cervical carcinoma cells can be induced to enter a senes-
cent state by transduction of the bovine papillomavirus E2 gene,






Empty 54.0 ± 8.4 2.5 ± 1.0 80.7 ± 5.9
ShGLB#2 5.1 ± 1.4 6.5 ± 1.6 4.6 ± 1.2
ShLUC 49.6 ± 11.9 n.d. n.d.
*Two or more different fields with 50 or more cells were photographed, and 
number of cells stained blue with X-gal at pH 6.0 was divided by the total 
cell number.
n.d., not determined.
Fig. 2 Low SA-β-gal activity in GM1-gangliosidosis 
fibroblasts. (A) Fibroblasts at either early or late 
passage (at PD indicated in legend of Fig. 1B) were 
subjected to in situ SA-β-gal staining at pH 6, and 
examined by bright field microscopy. (B) 105 
normal (black bar), SKa (grey bar), and JNa (white 
bar) cells were collected at either early or late 
passage as in panel A and lysed in 100 µL of 0.1 
M phosphate buffer (pH 6.0), and equal volumes 
were assayed in solution for β-galactosidase 
activity at pH 6.0.
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which suppresses HPV18 oncogene expression and activates
tumor suppressor pathways in these cells (Hwang et al., 1993;
Goodwin et al., 2000; Wells et al., 2000). After expression of
the E2 protein, cells rapidly and irreversibly arrest in G1 phase,
and nearly 100% of them express a senescent phenotype,
including elevated SA-β-gal activity. HeLa cells were modified
to express decreased amounts of GLB1 mRNA by infecting with
the shGLB-retroviruses described above. In cells expressing
shGLB#2, GLB1 mRNA level was 8.1-fold lower than that in the
mock-treated cells as determined by real-time RT-PCR (data not
shown). The GLB1-knockdown and control HeLa cells were
infected with a virus that expressed the E2 protein, incubated
for 10 days, and assayed for the SA-β-gal activity in situ. The
parental HeLa cells infected with the E2 virus expressed the
expected senescent phenotype including growth arrest, in-
creased cell size and flattening, elevated autofluorescence and
high level SA-β-gal activity (Fig. 3C, left panels, and data not
shown). The GLB1-knockdown HeLa cells treated in parallel with
the E2 gene also underwent growth arrest and displayed
increased cell size and flattening and elevated autofluorescence
Fig. 3 Analysis of normal fibroblasts and HeLa cells 
expressing GLB1 shRNA. (A) and (B) Normal 
fibroblasts were infected with retroviruses 
expressing shRNA targeting the GLB1 mRNA 
(shGLB#1 and shGLB#2) or with a control retrovirus 
(shLUC), as indicated. Pooled puromycin-resistant 
cells were subjected to an assay for β-galactosidase 
in solution at pH 4.5 (A) or to in situ staining for 
β-galactosidase at pH 6.0 (B). Normal late-passage 
fibroblasts were stained as controls. (C) HeLa or 
HeLa-shGLB#2 cells were either mock infected or 
infected with the E2 virus, incubated for 10 days, 
and subjected to in situ staining for β-galactosidase 
at pH 6.0.
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(Fig. 3C, right panels, and data not shown). Strikingly, on aver-
age < 5% of infected HeLa cells expressing the shGLB#2 RNA
stained positively for SA-β-gal activity in situ, whereas 80% of
the parental cells were positive (Fig. 3C and Table 1). Similar
results were obtained in an independent population of HeLa
cells generated by using the shGLB#1 virus (data not shown).
β-Galactosidase activity measured in solution at pH 6.0 showed
a progressive increase with increasing time after E2-infection of
the parental cells, with little activity present in the GLB1-knock-
down cells (data not shown). Thus, SA-β-gal activity in cancer
cells induced to enter senescence also requires expression of the
GLB1 gene. Taken together, these results indicate that SA-β-
gal activity originates from the GLB1 gene in both replicative
and induced senescence and that this activity is not required
for senescence.
Increased lysosomal β-galactosidase protein in 
fibroblasts undergoing senescence
Although a protein that cross-reacts with an antibody raised to
Escherichia coli β-galactosidase undergoes a progressive
increase in senescing cells (Kurz et al., 2000), the levels of lys-
osomal β-galactosidase protein have not been directly measured
during senescence. To determine whether increased levels of
lysosomal β-galactosidase protein accompanied the appearance
of SA-β-gal activity in senescent cells, we conducted Western
blotting with an antibody specific for human lysosomal β-
galactosidase (Zhang et al., 1994). Two samples each of early-
passage and late-passage normal fibroblasts were prepared
and normalized for either total protein content (Fig. 4, lanes 1–5)
or cell number (Fig. 4, lanes 6–9). The 85 kDa precursor and
the ∼64 kDa mature form of the lysosomal β-galactosidase are
readily detectable in early- and late-passage fibroblasts, except
in late-passage cells expressing the GLB1 shRNA (lane 5), as
expected. Strikingly, there was an approximately sixfold increase
in the amount of the 65 kDa protein band on a per cell basis
in late-passage compared to early-passage cells (compare lanes
6 and 7 to 8 and 9). Correspondingly, β-galactosidase activity
in solution increased approximately six- to sevenfold per cell in
late-passage fibroblasts undergoing senescence compared to
early-passage cells when the assay was conducted at either
pH 4.5 or 6.0, although the absolute level of activity was higher
at pH 4.5 in both early- and late-passage cells (data not shown).
Thus, increased SA-β-gal activity in senescent fibroblasts is due
at least in part to increased levels of lysosomal β-galactosidase.
Senescent cells are larger than early-passage cells, and approx-
imately 2.5-fold more protein or RNA is isolated from equal
numbers of late-passage compared to early-passage cells. Thus,
if lysosomal β-galactosidase protein (Fig. 4, lanes 1–4) or SA-β-
gal activity (data not shown) is expressed after normalization
for total protein content (rather than on a per-cell basis), the
increase in the senescent cells is approximately two- to threefold.
Levels of GLB1 RNA were measured by quantitative real-time
RT-PCR. This analysis revealed a 1.6-fold increase in the GLB1
mRNA in late-passage fibroblasts normalized to the levels of γ-
actin mRNA (average of independent measurements of three
different sets of RNA samples, data not shown). On a per-cell
basis, this corresponds to an approximately fourfold increase in
GLB1 mRNA in senescent cells.
Discussion
Since described in 1995 (Dimri et al., 1995), in situ SA-β-gal
activity has been widely used as a biomarker of senescence.
Although several lines of indirect evidence suggested that SA-
β-gal may be due to increased lysosomal β-galactosidase in
senescent cells, the origin of SA-β-gal activity and the basis for
induction has not been unequivocally established. In the present
study, we provide two compelling pieces of genetic evidence
that lysosomal β-galactosidase is the origin of SA-β-gal activity.
First, senescent human GM1-gangliosidosis fibroblasts lacking
lysosomal β-galactosidase due to homozygous inactivating
mutations in the GLB1 gene fail to express SA-β-gal activity;
second, SA-β-gal activity is greatly reduced in senescent cells
in which the concentration of GLB1 mRNA is reduced by RNA
interference. Our results, together with published results from
other laboratories (Kurz et al., 2000; Gerland et al., 2003; Gary
& Kindell, 2005; Yang & Hu, 2005), demonstrate that lysosomal
β-galactosidase activity increases enough in senescent cells
to be detected at suboptimal pH 6.0, constituting SA-β-Gal
activity. This increase appears to be due at least in part to the
accumulation of increased levels of GLB1 mRNA and protein.
However, the extent of the senescence-induced increase in
lysosomal β-galactosidase measured by Western blotting or
Fig. 4 Biochemical analysis of lysosomal β-
galactosidase expression. 4.5 x 105 normal human 
fibroblasts at two early passages (PD18 and 20) and 
two late passages (PD72 and 73) as well as NHF-
shGLB#2 at PD73 (lane 5) were lysed in 80 µL of 
RIPA buffer. Either equal mass of extracted protein 
(10 µg) (lanes 1–5) or equal volumes of extract (4 
× 104 cell equivalent) (lanes 6–9) were subjected 
to Western blotting for human lysosomal β-
galactosidase (top panel) or Erk-1/2 protein 
(bottom panel). The arrow indicates the lysosomal 
β-galactosidase band at approximately 64 kDa.
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soluble enzymatic activity appears much less than the induction
of SA-β-gal observed by in situ staining with X-gal. Thus, in
addition to increased amounts of lysosomal β-galactosidase in
senescent cells, functional differences in senescent lysosomes
or other factors may contribute to the very high levels of β-
galactosidase activity as assessed by in situ staining at pH 6.
Our finding that lysosomal β-galactosidase is the source of
SA-β-gal activity in senescent cells indicates that SA-β-gal is not
a specific marker of senescence per se, but rather a surrogate
marker for increased lysosome number or activity, which has
long been associated with replicative senescence and organismal
aging (Robbins et al., 1970; Brunk et al., 1973; Turk & Milo,
1974; Cristofalo & Kabakjian, 1975; Knook et al., 1975; Bosmann
et al., 1976; Sanchez-Martin & Cabezas, 1997; Gerland et al.,
2003). This is consistent with increased SA-β-gal activity in a
number of nonsenescent situations and suggests that other
conditions characterized by increased lysosomal content will
also display elevated β-galactosidase activity at pH 6.0, and,
conversely, that other lysosomal proteins are likely to increase
during senescence and may also serve as senescence markers.
Hence, SA-β-gal activity cannot stand alone to define a senescent
state. Rather, senescence is best defined as the appearance of a
constellation of features, only one of which is β-galactosidase
activity at pH 6. The identification of GLB1 as the gene encoding
SA-β-gal will allow a systematic evaluation of the factors that
control its expression in a variety of growth states, and thereby
improve its use as a marker of senescence.
Our results highlight two additional points regarding senes-
cence. First, GLB1 is essential for expression of SA-β-gal in both
replicative senescence and induced senescence, indicating at
least partial overlap in the programs that lead to these senes-
cence states. Second, the GM1-gangliosidosis cells undergo
senescence in response to serial passage or adriamycin treat-
ment, and GLB1 mRNA knockdown did not interfere with
senescence, even though it caused a substantial reduction in
SA-β-gal activity. Thus, SA-β-gal activity is not required for
senescence, and the increase in β-galactosidase activity in senes-
cent cells is an outcome rather than a cause of senescence.
Experimental procedures
Cell culture
Normal primary fibroblasts were isolated from healthy newborn
foreskins and provided by Dr Sang Chul Park (Seoul National
University, Korea) or the Yale Skin Diseases Research Center.
GM1-gangliosidosis fibroblasts (SKa and JNa cells) were isolated
from skin biopsies of two patients clinically diagnosed as
affected by GM1-gangliosidosis (patients 89RD0051 and
90RD0450, respectively). The DNA sequence of the GLB1 gene
from these patients was determined as described (Caciotti et al.,
2005). Fibroblast cultures were passaged in low glucose
(5.5 mM) DMEM containing 10% FBS at 1 : 4 ratio until the
Hayflick limit (Hayflick & Moorhead, 1961) was reached. The
number of population doublings (PD) was calculated using the
equation, PD = log2 F/I, where F and I are the numbers of cells
at the end and those seeded at the beginning of one passage,
respectively. To induce a state of senescence in early-passage
fibroblasts (PD18 for normal and SKa cells, and PD24 for JNa
cells), cells were treated with 0.5 µM adriamycin for 4 h and then
incubated in its absence for 5 days.
Senescence induction in HeLa cells
Senescence was induced in HeLa/E6.5K cells (DeFilippis et al.,
2003; referred to here as HeLa cells) as previously described
by infection at multiplicity of infection of 20 with an SV40-
recombinant virus (Pava1, designated here the E2 virus) express-
ing the bovine papillomavirus E2 protein (Hwang et al., 1993;
Goodwin et al., 2000). This treatment represses the human pap-
illomavirus (HPV) type 18 E7 gene, resulting in the acquisition
of a number of markers of senescence, including growth arrest
and an acute increase in SA-β-gal activity (Goodwin et al., 2000;
Kang et al., 2004).
Detection of autofluorescence
Cells grown on glass cover slips were washed with phosphate-
buffered saline (PBS), mounted in Gel/Mount (Biomeda, Foster
City, CA, USA), and observed by fluorescence microscopy with
an excitation filter (450–480 nm) and emission filter (520 nm)
at ×200 magnification. Autofluorescence in HeLa cells was
measured by fluorescence activated cell sorting as described
(Goodwin et al., 2000).
Western blotting analysis
Cells were lysed in RIPA buffer [50 mM Tris-HCl (pH 7.5),
150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate,
0.1% SDS] supplemented with protease inhibitor mixture
(Sigma-Aldrich, St. Louis, MO, USA), NaF, and NaVO4. Twenty µg
protein were subjected to gel electrophophoresis as described
(DeFilippis et al., 2003) and analyzed by Western blotting using
antip53 (DO-1; Calbiochem, San Diego, CA, USA), antip21WAF1
(C-19; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-
Rb (BD Biosciences, Franklin Lakes, NJ, USA), or anti-ERK 1/2
antibody. To detect lysosomal β-galactosidase protein, lysate
from an equal number of cells or 20 µg of extracted protein
were electrophoresed and probed with a human lysosomal
β-galactosidase specific polyclonal antiplacental β-galactosidase
IgG, kindly provided by John Callahan (Hospital for Sick Chil-
dren, Toronto, ON, Canada) (Zhang et al., 1994). Protein bands
were quantitated by using the ImageQuant 5.2 program (Amer-
sham Biosciences, Piscataway, NJ, USA).
In situ staining for β-galactosidase activity
Cultured cells were washed in PBS (pH 7.4), fixed with 3.7%
formaldehyde, and incubated overnight at 37 °C in freshly pre-
pared staining buffer [1 mg mL−1 X-gal (5-bromo-4-chloro-3-indolyl
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β-D-galactoside), 5 mM K3Fe[CN]6, 5 mM K4Fe [CN]6, and 2 mM
MgCl2 in PBS, pH 6.0, or in citrate-buffered saline, pH 4.5]. At
the end of the incubation, cells were washed with H2O and
examined at ×200 magnification.
Soluble β-galactosidase assay
Equal numbers of cells were collected, washed and resuspended
in either 0.1 M citrate (pH 4.5) or phosphate buffer (pH 6.0).
Cells were lysed by freeze/thaw. The lysates were centrifuged
at 12 000 g for 7 min. The supernatants were mixed with 2-
nitrophenyl-β-D-galactopyranoside (ONPG) (Sigma) (2.2 µg µL−1),
1 mM MgCl2 in either the citrate or phosphate buffer. After
incubation at 37 °C for 12 h, two volumes of 1 M sodium car-
bonate were added and absorbance at 420 nm was measured.
Knockdown of lysosomal β-galactosidase RNA
To generate retroviral vectors that express small hairpin RNA
(shRNA) uniquely targeting the human GLB1 mRNA (M34423),
oligodeoxyribonucleotides containing 21-base target sequences
(sh#1: 5′-ATGTAGCGAAATGGCTGGCCA-3′; sh#2: 5′-AAGT-
GTTGTCCGGTACAGCAC-3′) were annealed and ligated into
pSIREN-RetroQ (BD Biosciences, San Jose, CA, USA) 3′ to the
human U6 promoter. The presence of the correct inserts was
confirmed by sequencing. A control vector that expresses
shRNA targeting Photinus luciferase (RV-shLUC) (BD Bio-
sciences) was constructed in parallel. Retroviruses were pack-
aged in 293T cells and concentrated. Pre-senescent normal
fibroblasts (PD62) and HeLa cells were infected with these
viruses individually and selected for 3–14 days for resistance to
0.4 µg mL−1 puromycin and then pooled. The resistant pools
were maintained by continuous passage in 0.2 µg mL−1 puro-
mycin. RNA was isolated using RNeasy kit (QIAGEN Sciences,
Germantown, MD, USA) and converted to cDNA using iScript
cDNA Synthesis kit (Bio-Rad, Hercules, CA, USA) by following
manufacturer’s protocols. The protocol used to quantitate GLB1
and γ-actin mRNA by single-color quantitative Real-Time PCR
(Bio-Rad) is available from the authors upon request.
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